ليست عنوان مقالات لاتين Neuromuscular implications in left ventricular hypertrabeculation/noncompaction Neutral and dianionic iron and ruthenium 1,4-diphosphabutadiene complexes

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Neuromuscular implications in left ventricular hypertrabeculation/noncompaction

2

Neuromuscular mechanisms and anthropometric modifications in the initial stages of independent gait

3

Neuromuscular Mechanisms of Primary Peristalsis

4

Neuromuscular neutral zones response to cyclic lumbar flexion

5

Neuromuscular neutral zones response to static lumbar flexion: Muscular stability compensator

6

Neuromuscular neutral zones sensitivity to lumbar displacement rate

7

Neuromuscular objectives of the human masticatory apparatus during static biting

8

Neuromuscular Problems in the Patients With COVID-19: A Review Study

9

Neuromuscular recovery in ACL reconstruction with Bone-Tendon-Patellar-Bone and Semitendinosus-Gracilis autograft

10

Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial

11

Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy

12

Neuromuscular variables affecting the magnitude of force loss after eccentric exercise

13

Neuromuscular versus behavioural influences on reaching performance in young and elderly women

14

Neuromyelitis optica — Devicʹs syndrome, update

15

Neuromyelitis Optica and Nucleotide Variations of Aquaporin-4 Gene

16

Neuromyelitis optica in a patient with an early onset demyelinating episode: Clinical and autoantibody findings

17

Neuromyelitis optica in a pregnant woman with systemic lupus erythematous: A case report

18

Neuromyelitis Optica in Children: A Rare Entity

19

Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross‑sectional study

20

Neuromyelitis optica: what it is and what it might be

21

22

Neuromyotonia, myocloni, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu-antibodies)

23

Neuromythology of Einstein’s brain

24

Neuron Cell Type-specific SNAP-25 Expression Driven by Multiple Regulatory Elements in the Nematode Caenorhabditis elegans

25

Neuron death due to unfolded protein response in gangliosidosis

26

Neuron death in ALS may be due to effects of neighbours

27

Neuron firing in driven nonlinear integrate-and-fire models

28

Neuron loss after coronary artery bypass detected by SPECT estimation of benzodiazepine receptors

29

Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis Review Article

30

Neuron Mathematical Model Representation of Neural Tensor Network for RDF Knowledge Base Completion

31

Neuron Numbers and Volume of the Amygdala in Subjects Diagnosed with Bipolar Disorder or Schizophrenia

32

Neuron source energy on resonance absorption

33

Neuronal activation and plasticity in Schistosoma mansoni infected mice

34

Neuronal activation in response to isoproterenol (Iso) in 6-day-old rat pups

35

Neuronal activity in the basal ganglia and thalamus in patients with dystonia

36

Neuronal and glial cell types revealed by NADPH-diaphorase histochemistry in the retina of a teleost fish, the grass goby (Zosterisessor ophiocephaluSy Perciformes, Gobiidae)

37

Neuronal and glial changes in the brain resulting from explosive blast in an experimental model

38

Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain

39

Neuronal and microglial cathepsins in aging and age-related diseases

40

Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer

41

Neuronal Approach and the Use of KIK-NET Network to Generate Response Spectrum on the Surface

42

Neuronal assemblies: necessity, signature and detectability

43

Neuronal autoantibodies in focal epilepsy with or without mesial temporal sclerosis

44

Neuronal BC1 RNA: Microtubule-dependent Dendritic Delivery

45

Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease

46

Neuronal Cell Death in the Ischemic Spinal Cord: The Effect of Methylprednisolone

47

Neuronal cell death, nerve growth factor and neurotrophic models: 50 years on

48

Neuronal cell protective and antioxidant effects of phenolics obtained from Zanthoxylum piperitum leaf using in vitro model system

49

Neuronal Cell Reconstruction with Umbilical Cord Blood Cells in the Brain Hypoxia-Ischemia

50

Neuronal ceroid lipofuscinosis in a 31-year-old woman presenting as biventricular heart failure with restrictive features

51

Neuronal ceroid-lipofuscinosis: late infantile form or juvenile form?

52

Neuronal Changes in Normal Human Aging and Alzheimerʹs Disease

53

Neuronal circuitries involved in thermoregulation

54

Neuronal codes: reading them and learning how their structure influences network organization

55

Neuronal computers Original Research Article

56

Neuronal connections of the paratrigeminal nucleus: a topographic analysis of neurons projecting to bulbar, pontine and thalamic nuclei related to cardiovascular, respiratory and sensory functions

57

Neuronal contact guidance in magnetically aligned fibrin gels: effect of variation in gel mechano-structural properties

58

Neuronal Control of Metabolism through Nutrient-Dependent Modulation of Tracheal Branching

59

Neuronal correlates of “free will” are associated with regional specialization in the human intrinsic/default network

60

Neuronal Correlates of Colour-Graphemic Synaesthesia: Afmri Study

61

Neuronal correlates of context-related behavior

62

Neuronal Correlates of Obsessions in the Caudate Nucleus

63

Neuronal damage after hypothermic circulatory arrest and retrograde cerebral perfusion in the pig

64

Neuronal damage of the dorsal hippocampus induced by long-term right common carotid artery occlusion in rats

65

Neuronal death in the central nervous system during development

66

Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection

67

Neuronal differentiation modifies the effect of ethanol exposure on voltage-dependent calcium channels in NG 108-15 cells

68

Neuronal differentiation of induced pluripotent stem cells in hybrid polyester scaffolds with heparinized surface

69

Neuronal differentiation of mouse amnion membrane derived stem cells in response to neonatal brain medium

70

Neuronal Differentiation of Mouse Embryonic Stem Cells: Lineage Selection and Forced Differentiation Paradigms

71

Neuronal Differentiation of Rat Hair Follicle Stem Cells: the Involvement of the Neuroprotective Factor Seladin-1 (DHCR24)

72

Neuronal DNA damage correlates with overexpression of interleukin-1β converting enzyme in APPV717F mice

73

Neuronal effects of auditory distraction on visual attention

74

Neuronal Environment: the Brain Homeostasis in Health and Disease: W. Waltz, Humana Press, ISBN 0-89603-882-3, $145.00

75

Neuronal event detection in fMRI time series using iterative deconvolution techniques

76

Neuronal evolution: analysis of regulatory genes in a first-evolved nervous system, the hydra nervous system

77

Neuronal expression of Raf protooncogene in the brain stem of adult guinea pig

78

Neuronal feedback between brain and inner ear for growth of otoliths in fish Original Research Article

79

Neuronal firing activity in the dorsal hippocampus during the auditory discrimination oddball task in awake rats: relation to event-related potential generation

80

Neuronal function in chronic spinal cord injury: Divergence between locomotor and flexion- and H-reflex activity

81

Neuronal injury and death following focal mild brain injury: The role of network excitability and seizure

82

Neuronal Innervation, Intracellular Signal Transduction and Intercellular Coupling: a Model for Syncytial Tissue Responses in the Steady State

83

Neuronal Inputs from the Hypothalamus and Brain Stem to the Medial Preoptic Area of the Ram: Neurochemical Correlates and Comparison to the Ewe

84

Neuronal instability: implications for Rettʹs syndrome

85

Neuronal insulin signal transduction mechanisms in diabetes phenotypes

86

Neuronal intranuclear inclusion disease: neuropathologic study of a case

87

Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity

88

Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity

89

Neuronal lipofuscinosis

90

Neuronal loss and β-amyloid removal in the amygdala of people with Down syndromesmall star, filled

91

Neuronal loss in the colon of constipated Parkinsonʹs disease patients mimics that in the brain

92

Neuronal MAP2 mRNA: Species-dependent Differential Dendritic Targeting Competence

93

Neuronal maturation and N-acetyl-l-aspartic acid development in human fetal and child brains

94

Neuronal mechanisms mediating drug-induced cognition enhancement: cognitive activity as a necessary intervening variable

95

Neuronal Microtubule-associated Proteins: Insights into Their Structures and Functions

96

Neuronal migrational disorders in children with epilepsy: MRI, interictal SPECT and EEG comparisons

97

Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues

98

Neuronal nicotinic receptors and epilepsy, from genes to possible therapeutic compounds

99

Neuronal nicotinic receptors and ligands

100

Neuronal nitric oxide synthase (NNOS) catalyzes one-electron reduction of 2,4,6-trinitrotoluene, resulting in decreased nitric oxide production and increased nNOS gene expression: implication for oxidative stress

101

Neuronal nitric oxide synthase activity is increased during granulomatous inflammation in the colon and caecum of pigs infected with Schistosoma japonicum

102

Neuronal Nitric Oxide Synthase Expression in the Anterior Vaginal Wall of Patients with Stress Urinary Incontinence

103

Neuronal nitric oxide synthase gene transfer decreases [Ca2+]i in cardiac sympathetic neurons

104

Neuronal Nitric Oxide Synthase is Refractory to Mechanism-Based Inactivation in GH3Pituitary Cells

105

Neuronal Nitric Oxide Synthase–Membrane Phospholipid Interactions

106

Neuronal NO synthase (NOS1) is a major candidate gene for asthma

107

Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in the early human fetal nervous system

108

Neuronal organization and cell interactions of the cat stellate ganglion

109

Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging

110

Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity

111

Neuronal Phenomena Associated with Vigilance and Consciousness: From Cellular Mechanisms to Electroencephalographic Patterns,

112

Neuronal plasticity and survival in mood disorders

113

Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes

114

Neuronal porosome – The secretory portal at the nerve terminal: Its structure–function, composition, and reconstitution

115

Neuronal projections from ventral tegmental area to forebrain structures in rat studied by manganese-enhanced magnetic resonance imaging

116

Neuronal representations of cognitive state: reward or attention?

117

Neuronal stem cells: a tale of promise and caution

118

Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntingtonʹs Disease Treatment Original Research Article

119

Neuronal subpopulations and genetic background in tauopathies: a catch 22 story?

120

Neuronal subserving of behavior before and after chronic ethanol treatment

121

Neuronal substrates of sensory gating within the human brain

122

Neuronal substrates participating in attentional set-shifting of rules for visually guided motor selection: a functional magnetic resonance imaging investigation

123

Neuronal Subtype Specification within a Lineage by Opposing Temporal Feed-Forward Loops

124

Neuronal susceptibility to damage: comparison of the retinas of young, old and old/caloric restricted rats before and after transient ischemia

125

Neuronal synchrony detection on single-electron neural networks

126

Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Downʹs syndrome: a gene expression study

127

Neuronal toxicity of biopolymer-template synthesized ZnO nanoparticles

128

Neuronal, mesenchymal and hematopoietic cell derived from CD34− lin− cell from adult bone marrow

129

Neuronally-expressed necdin gene: an imprinted candidate gene in Prader-Willi syndrome

130

Neuronavigated repetitive transcranial magnetic stimulation in patients with tinnitus: a short case series

131

Neuronavigation assisted endoscopic sinus surgery

132

Neuronavigation for Intraoperative Localization of Cerebral Aneurysms

133

Neuronavigation for transcranial magnetic stimulation (TMS): Where we are and where we are going

134

Neuron-based VLSI architecture for real-time camera distortion correction

135

Neuron-controlled robots

136

Neuron-MOS Parallel Search Hardware for Real-Time Signal Processing

137

Neuronorm is a potent and water soluble neurokinin A receptor antagonist

138

Neurons and neuronal systems involved in the pathophysiologies of Rett syndrome

139

Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimerʹs disease

140

Neurons don’t represent

141

Neurons in amygdala mediate ear pinna vasoconstriction elicited by unconditioned salient stimuli in conscious rabbits

142

Neurons lose inhibitions in epilepsy

143

Neurons regenerate in absence of reactive astrocytes

144

Neurons, Cooperativity and the Role of Noise in Brain

145

Neurons, glia, and plasticity in normal brain aging

146

Neurons, viscose fluids, freshwater polyp hydra-and self-organizing information systems

147

Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke

148

Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome

149

Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome

150

Neuron-Specific enolase as a marker for acute ischemic stroke: A systematic review

151

Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy

152

Neuron-specific enolase in cerebrospinal fluid as a neurochemical marker for brain damage in acute lymphoblastic leukemia

153

Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation

154

Neuron-specific enolase levels in the cerebrospinal fluid of neurologically healthy children

155

Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis

156

Neuron-specific susceptibility to apolipoprotein E4

157

Neuron-synapse IC chip-set for large-scale chaotic neural networks

158

Neuron-tumor Interaction in Prostate Cancer: Implications and Future Perspective

159

Neuron-type polypyrrole device prepared by electrochemical polymerization method and its properties

160

Neuro-oncology for non-oncologists

161

Neuro-oncology for Nurses; Edited by Douglas Guerrero, Whur Publishers Ltd, £24.50

162

Neuro-oncology: diagnosis in the spotlight

163

Neuro-oncology: new insights and advances in treatment

164

Neuro-oncology: oligodendroglioma and molecular markers

165

Neuro-oncology: setting new standards of management

166

Neuro-oncology: the growing role of chemotherapy in glioma

167

Neuro-Ophthalmologic and Electroretinographic Finding in Pantothenate Kinae-Aociated Neurodegeneration (formerly Hallervorden-patz yndrome)

168

Neuro-Ophthalmologic Preentation of Hemicrania Continua

169

Neuro-ophthalmologic Recovery Following Endoscopic Endonasal Resection of Pituitary Macro-adenomas with Apoplexy

170

Neuro-ophthalmology review manual, revied 5th edition: Lanning B. Kline and Frank J. Bajanda. lack Incorporated: Thorofare, NJ; 2004.288 page$44.95 UDIBN 1-55642-672-0Media type: Review Manual

171

Neuro-Ophthalmology, The Requiite in Ophthalmology. Edited by Timothy J. Martin and Jame J. Corbett. t. Loui, Miouri, Moby Inc., 2000. Index, illutrated, 256 page. $89.00.

172

Neuro-ophthalmology: Neuronal Control of Eye Movements .A. Straube and U. Büttner Editors Basel Karger (2007).

173

Neuro-ophthalmology—Diagnoi and Management. Liu GT, Volpe NJ, Baletta L. New York, W.B. aunder, 2001. 756 page, index, illutrated. About $135.00

174

Neuro-optimal operation of a variable air volume HVAC&R system

175

Neuro-Optometry, Neuro-Optometrist, and Neuro-Optometric Rehabilitative Implications

176

Neuro-otologic Manifestations of Multiple Sclerosis

177

Neuro-otological features of Benign Paroxysmal Vertigo and Benign Paroxysmal Positioning Vertigo in children: A follow-up study

178

Neuropathic agents and pain. New strategies

179

Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases

180

Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases

181

Neuropathic diabetic patients do not have reduced variability of plantar loading during gait

182

Neuropathic elbow arthropathy: A review of six cases

183

Neuropathic gait shows only trends towards increased variability of sagittal plane kinematics during treadmill locomotion

184

Neuropathic injury to the levator ani occurs in 1 in 4 primiparous women

185

Neuropathic manifestations in rheumatoid arthritis : A clinical and electrophysiological assessment in a small sample of Iraqi patients.

186

Neuropathic Orofacial Pain: Proposed Mechanisms, Diagnosis, and Treatment Considerations

187

Neuropathic Osteoarthropathy in a Patient with Congenital Insensitivity to Pain

188

Neuropathic pain

189

NEUROPATHIC PAIN

190

Neuropathic pain

191

Neuropathic pain in hereditary coproporphyria

192

Neuropathic pain in soft tissue complaints

193

Neuropathic pain research pinpoints new role for microglia

194

Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail

195

Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail

196

Neuropathic Pain: A Review of Interneuronal Disinhibition

197

Neuropathic pain: aetiology, symptoms, mechanisms, and management

198

Neuropathic symptoms and findings in women with Fabry disease

199

Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature

200

Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature

201

Neuropathies of the foot

202

Neuropathogenicity of Equine Herpesvirus 9 in Cattle

203

Neuropathologic study of long term cyanide administration to goats

204

Neuropathological alteration of aquaporin 1 immunoreactive enteric neurons in the streptozotocin-induced diabetic rats

205

Neuropathological analysis of the brainstem and cerebral cortex lesions on epileptogenesis in hereditary dentatorubral-pallidoluysian atrophy

206

Neuropathological assessment of artemether-treated severe malaria

207

Neuropathological Changes in Brain Cortex and Hippocampus in a Rat Model of Alzheimer’s Disease

208

NEUROPATHOLOGICAL CHANGES IN THE PDAPP TRANSGENIC MOUSE MODEL OF ALZHEIMER S DISEASE

209

Neuropathological characteristics and alteration of the dopamine D2 receptor in hypoxic-ischemic basal ganglia necrosis

210

Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease

211

Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease: Are We Really Ready Yet?

212

Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies

213

Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms

214

Neuropathological findings in the cerebro-oculo-facio-skeletal (Pena-Shokeir II) syndrome

215

Neuropathological markers of impaired cognition in the entorhinal cortex

216

Neuropathological Staging of Alzheimer-Related Lesions: The Challenge of Establishing Relations to Age

217

Neuropathological studies of brain tissue in schizophrenia

218

Neuropathologies of the self: Clinical and anatomical features

219

Neuropathology and Genetics of Dementia, Edited by Tolnay M. and Probst A., Kluwer Academic/Plenum Publ., London, 2000.

220

Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging

221

Neuropathology of bipolar disorder

222

Neuropathology of chronic chagasic cardiopathy: A diagnostic reassessment

223

Neuropathology of developmental abnormalities

224

Neuropathology of early-infantile epileptic encephalopathy with suppression-bursts; comparison with those of early myoclonic encephalopathy and West syndrome

225

Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs

226

Neuropathology of prion diseases

227

Neuropathology of the limbic system and brainstem in West syndrome

228

Neuropathology of tuberous sclerosis

229

Neuropathology of variant Creutzfeldt-Jakob disease

230

Neuropathy complicating diffuse infiltrative lymphocytosis

231

Neuropathy in type 1 diabetic renal transplanted patients

232

Neuropathy of the suprascapular nerve and massive rotator cuff tears: a prospective electromyographic study

233

Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease

234

Neuropathy-induced osteopenia in rats is not due to a reduction in weight born on the affected limb

235

Neuro-PD Controller of Structural System to Mitigate Earthquake Vibrations

236

Neuropeptide deficits in schizophrenia vs. Alzheimerʹs disease cerebral cortex

237

Neuropeptide deficits in schizophrenia vs. Alzheimerʹs disease cerebral cortex

238

Neuropeptide Delivery to Synapses by Long-Range Vesicle Circulation and Sporadic Capture

239

Neuropeptide enzyme hydrolysis in human saliva

240

Neuropeptide expression following ligation of the ferret lingual nerve

241

Neuropeptide expression in the ferret trigeminal ganglion following ligation of the inferior alveolar nerve

242

Neuropeptide FF attenuates RANKL-induced differentiation of RAW264.7 cells into osteoclast-like cells

243

Neuropeptide may shift rheumatoid arthritis into remission

244

Neuropeptide specificity of prostaglandin E2-induced activation of splenic and renal sympathetic nerves in the rat

245

Neuropeptide transmitters released from VAN into the NTS play an important role in regulating food intake

246

Neuropeptide Y (NPY) and NPY Y1 receptor in periodontal health and disease

247

Neuropeptide Y (NPY) revealed biological activity in leucocytes of Salmo salar

248

Neuropeptide Y (NPY): Genetic Variation in the Human Promoter Alters Glucocorticoid Signaling, Yielding Increased NPY Secretion and Stress Responses

249

Neuropeptide Y administered into cerebral ventricles stimulates sucrose ingestion in the near-term ovine fetus

250

Neuropeptide Y administration into the amygdala does not affect ethanol consumption

251

Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women

252

Neuropeptide Y expression, localization and cellular transducing effects in HUVEC

253

Neuropeptide Y Gene Promoter -399T/C Polymorphism Increases Risk of Ischemic Stroke

254

Neuropeptide Y immunohistochemistry and ultrastructure of developing chromaffin tissue in the cloudy dogfish, Scyliorhinus torazame (Chondrichthyes, Elasmobranchii)

255

Neuropeptide Y in male and female brains of flinders sensitive line, a rat model of depression. Effects of electroconvulsive stimuli

256

Neuropeptide Y in neural crest-derived tumors: Effect on growth and vascularization

257

Neuropeptide Y in the rostral ventrolateral medulla blocks somatosympathetic reflexes in anesthetized rats

258

Neuropeptide Y Inhibits in Vivo Specific Antibody Production in Rats

259

Neuropeptide Y modulation of sympathetic activity in myocardial infarction

260

Neuropeptide Y mRNA expression in interneurons in rat spinal cord

261

Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation

262

Neuropeptide Y receptors; antisecretory control of intestinal epithelial function

263

Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway

264

Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep

265

Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: The Helsinki Sudden Death Study

266

Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non–ethanol-abstinent, Wistar rats

267

Neuropeptide Y Y1 receptor functional responsiveness is enhanced during cardiomyocyte hypertrophy

268

Neuropeptide Y, α-melanocyte–stimulating hormone, and monoamines in food intake regulation

269

Neuropeptide Y1 Receptor NPY1R: Discovery of Naturally Occurring Human Genetic Variants Governing Gene Expression In Cella as Well as Pleiotropic Effects on Autonomic Activity and Blood Pressure In Vivo

270

Neuropeptide Y1 receptor NPY1R: discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo.

271

Neuropeptide Y-Y1 receptor modulates nitric oxide level during stroke in the rat

272

NEUROPEPTIDES (SP an‎d CGRP) AUGMENT IL-1 BETA PRODUCTION IN HSV-INFECTED MACROPHAGES

273

Neuropeptides and endothelial injury in cutaneous vasculitis

274

Neuropeptides and obesity

275

Neuropeptides: opportunities for drug discovery

276

Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report

277

Neuropharmacological activity of the aqueous leaf extract of Croton zambesicus (euphorbiaceae) in some laboratory animals

278

Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson’s disease

279

Neuropharmacological Effect of the Rhizome of Drynaria quercifolia in Mice

280

Neuropharmacological Effects of Chassalia curviflora (Rubiaceae) Leaves in Swiss Albino Mice Model

281

Neuro-pharmacological effects of Crinum zeylanicum in mice

282

Neuropharmacological effects of methanolic extracts of Rubus fruticosus L.

283

Neuropharmacological effects of Nigella sativa

284

Neuropharmacological effects of Ocimum basilicum and its constituents

285

Neuropharmacological effects of standardized aqueous stem bark extract of Parkia biglobossa in Wistar rats

286

Neuropharmacological key to cortical plasticity found

287

Neuropharmacological properties of farnesol in Murine model

288

Neuropharmacological studies of ethanolic extract of Vaccinium corymbosum on Alzheimer’s type dementia and catatonia in Swiss albino mice

289

Neuropharmacological studies with spect in neuropsychiatric disorders

290

Neuropharmacology of depression in aging and age-related diseases

291

Neuropharmacology of endogenous, synthetic andphytocannabinoids for pain management

292

Neuropharmacology of timing and time perception

293

Neuropharmacology of timing and time perception: [Cognitive Brain Research 3 (1996) 227–242]

294

Neurophenomenology and the study of self-consciousness

295

Neurophil reactive chlorinating species target tissue plasmalogens: Production of 2-chlorohexadecal

296

Neurophysical theory of coherence and correlations of electroencephalographic and electrocorticographic signals

297

Neurophysiologic and intellectual evaluation of beta-thalassemia patients

298

Neurophysiologic assessment of mucopolysaccharidosis III

299

Neurophysiologic consequences of neonatal ethanol exposure in the rat

300

Neurophysiologic correlates of deficient phonological representations and object naming in prematurely born children

301

Neurophysiologic correlates of psychiatric disorders and potential applications in epilepsy

302

Neurophysiologic detector—a selective and sensitive tool in high-performance liquid chromatography

303

Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy

304

Neurophysiological and behavioral concomitants of mild brain injury in collegiate athletes

305

Neurophysiological and behavioral indices of time pressure effects on visuomotor task performance

306

Neurophysiological and behavioural evidence for an olfactory function for the dorsal organ and a gustatory one for the terminal organ in Drosophila melanogaster larvae

307

Neurophysiological and functional MRI evidence of reorganization of cortical motor areas in cerebral arteriovenous malformation

308

Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes

309

Neurophysiological assessment of the sedative and analgesic effects of a constant rate infusion of dexmedetomidine in the dog

310

Neurophysiological assessment of trigeminal nerve reflexes in disorders of central and peripheral nervous system

311

Neurophysiological bases underlying the organization of intentional actions and the understanding of others’ intention

312

Neurophysiological changes associated with psychiatric symptoms in HIV-infected individuals without AIDS

313

Neurophysiological Changes Associated with Selective Neuronal Damage in Hippocampus following Transient Forebrain Ischemia

314

Neurophysiological characteristics of photophobia in migraine

315

Neurophysiological correlate of clinical signs in Parkinsonʹs disease

316

Neurophysiological Correlates of Affiliative Behaviour between Humans and Dogs

317

Neurophysiological correlates of subjective significance

318

Neurophysiological correlates of the recognition of facial expressions of emotion as revealed by magnetoencephalography

319

Neurophysiological effects of recurrent laryngeal and thoracic vagus nerves on mediating the neurogenic inflammation of the trachea, bronchi, and esophagus of rats

320

Neurophysiological evaluation of symptomatically unaffected muscles in post polio syndrome (PPS)

321

Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine

322

Neurophysiological evidence for categorical perception of color

323

Neurophysiological evidence of cognitive inhibition anomalies in persons with major depressive disorder

324

Neurophysiological follow-up of motor cortical output in stroke patients

325

Neurophysiological index is a marker of functional impairment in amyotrophic lateral sclerosis

326

Neurophysiological indices of attention to speech in children with specific language impairment

327

Neurophysiological indices of strategy development and skill acquisition

328

Neurophysiological investigation of a chronic sensory ataxia

329

Neurophysiological marker of inhibition distinguishes language groups on a non-linguistic executive function test

330

Neurophysiological markers in familial amyloid polyneuropathy patients: Early changes

331

Neurophysiological markers of contextual processing: The relationship between P3b and Gamma synchrony and their modulation by arousal, performance and individual differences

332

Neurophysiological markers of early language acquisition: from syllables to sentences

333

Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans.: Part 1. Recovery time of corticospinal tract direct waves elicited by pairs of transcranial electrical stimuli

334

Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans.: Part 2. Relationship between epidurally and muscle recorded MEPs in man

335

Neurophysiological Methods in Occupational and Environmental Health: Methodology and Recent Findings

336

Neurophysiological monitoring in vascular surgery

337

Neurophysiological Responses to Traumatic Reminders in the Acute Aftermath of Serious Motor Vehicle Collisions Using [15O]-H2O Positron Emission Tomography

338

Neurophysiological self-control: Modulation in all things

339

Neurophysiological signals of working memory in normal aging

340

Neurophysiological signs of cocaine dependence: Increased electroencephalogram beta during withdrawal

341

Neurophysiological study in Pelizaeus-Merzbacher disease

342

Neurophysiological study of corticomotor pathways in restless legs syndrome

343

Neurophysiological study of facial chorea in patients with Huntingtonʹs disease

344

Neurophysiological study of secondary synchronous occipito-frontopolar spikes in childhood

345

Neurophysiological study on possible protective and therapeutic effects of Sidr (Zizyphus spina-christi L.) leaf extract in male albino rats treated with pentylenetetrazol

346

Neurophysiological study on sensorimotor control mechanism in superior colliculus of echolocating bat

347

Neurophysiological techniques in patients who are secondarily non-responsive to Botulinum toxin

348

Neurophysiologist reprimanded by UK General Medical Council

349

Neurophysiology and neuroanatomy of reflexive and volitional saccades as revealed by lesion studies with neurological patients and transcranial magnetic stimulation (TMS)

350

Neurophysiology and neuroanatomy of reflexive and volitional saccades: Evidence from studies of humans

351

Neurophysiology and neuroanatomy of reflexive and voluntary saccades in non-human primates

352

Neurophysiology and neuroanatomy of smooth pursuit in humans

353

Neurophysiology and neuroanatomy of smooth pursuit: Lesion studies

354

Neurophysiology for Detection of High Risk for Psychosis

355

Neurophysiology in the intensive care unit: Size (of surals) matters

356

Neurophysiology of Parkinsonʹs disease: from basic research to clinical correlates

357

Neurophysiology of Rett syndrome

358

Neurophysiology of Social Conduct and Impact of Adverse Exposures

359

Neurophysiology of spasms

360

Neurophysiology of swallowing

361

Neurophysiology of the neurogenic lower urinary tract disorders

362

Neurophysiology of Touretteʹs syndrome: pathophysiological considerations

363

Neurophysiology of unimanual motor control and mirror movements

364

Neurophysiology reference tome

365

Neuro-PID tracking control of a discharge air temperature system

366

Neuropil Alteration of the Habenula Nucleus in the Experimental Model of Schizophrenia Induced by Ketamine

367

Neuropilin-1 Expreion by Endothelial Cell and Retinal Pigment Epithelial Cell in Choroidal Neovacular Membrane

368

Neuropilins and semaphorins — from angiogenesis to autoimmunity

369

Neuroplasticity and schizophrenia

370

Neuroplasticity as a function of second language learning: Anatomical changes in the human brain

371

Neuroplasticity changes during space flight Original Research Article

372

Neuroplasticity Changes of Rat Brain by Musical Stimuli during Fetal Period

373

Neuroplasticity of face primary motor cortex control of orofacial movements

374

Neuroplasticity of face sensorimotor cortex and implications for control of orofacial movements

375

Neuroplasticity: Evidence from aphasia

376

Neuropolitics gone mad

377

Neuroprophylaxis with aminophylline and magnesium sulfate?

378

Neuroprostheses for leg function after spinal-cord injury

379

Neuroprotection after cardiac arrest

380

Neuroprotection After Traumatic Brain Injury: Is There any Hope?

381

Neuroprotection against ischemic brain injury conferred by a novel nitrate ester

382

Neuroprotection and anxiety like behavior reduction of Allium hirtifolium and Astragalus hamosus in the AB-injected rat

383

NEURO-PROTECTION AND NEURO-THERAPY EFFECTS OF Acalypha indica Linn. WATER EXTRACT EX VIVO ON Musculus gastrocnemius Frog

384

Neuroprotection and pharmacotherapy for motor symptoms in Parkinsonʹs disease

385

Neuroprotection and the role of neuroglobin

386

Neuroprotection by KATP channels

387

Neuroprotection by the Metabolic Antioxidant α-Lipoic Acid

388

Neuroprotection disappointment yet aGAIN

389

Neuroprotection Effect of Quercetin on TNF- Levels and Gene Expression of Caspase 3 in MPTP-Induced Male NMRI Mice

390

Neuroprotection failure in stroke

391

Neuroprotection for acute ischaemic stroke: hope reignited

392

Neuroprotection for Parkinsonʹs disease: a call for clinically riven experimental design

393

Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?

394

Neuroprotection in Cardiac Surgery

395

Neuroprotection in epilepsy: The Holy Grail of antiepileptogenic therapy

396

Neuroprotection in Glaucoma

397

Neuroprotection in Glaucoma

398

Neuroprotection in multiple sclerosis

399

Neuroprotection in Parkinsonʹs Disease

400

Neuroprotection in Parkinsonʹs disease: and now for something completely different?

401

Neuroprotection of a sesamin derivative, 1, 2-bis [(3-methoxy- phenyl) methyl] ethane-1, 2-dicaroxylic acid (MMEDA) against ischemic and hypoxic neuronal injury

402

Neuroprotective (+) 3S, 4S cannabinoids with modified 5′-side chain

403

Neuroprotective activities of acai berries (Euterpe sp.): A review

404

Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: Quantification with immunohistochemical for calcium–binding proteins

405

Neuroprotective adaptations in hibernation: therapeutic implications for ischemia-reperfusion, traumatic brain injury and neurodegenerative diseases

406

Neuroprotective Agents for Management of Parkinson’s disease

407

Neuroprotective agents: Cannabinoids

408

Neuroprotective and Antiamnesic Effects of Mitragyna inermis Willd (Rubiaceae) on Scopolamine-Induced Memory Impairment in Mice

409

Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines

410

Neuroprotective and Anti-inflammatory Role of Atorvastatin and Its Interaction with Nitric Oxide (NO) in Chronic Constriction Injury-induced Neuropathic Pain

411

Neuroprotective and anti-neuroinflammatory activity of frankincense in bile duct ligation-induced hepatic encephalopathy

412

Neuroprotective and memory enhancing effects of Zataria multiflora in lipopolysaccharide-treated rats

413

Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior

414

Neuroprotective and Nootropic Activity of Carica Papaya Seeds on Diabetes induced Cognitive Decline in Rats

415

Neuroprotective and Nootropic Drug Noopept Rescues α-Synuclein Amyloid Cytotoxicity

416

Neuroprotective antioxidant effect of sex steroid hormones in traumatic brain injury

417

Neuroprotective biflavonoids of Chamaecyparis obtusa leaves against glutamate-induced oxidative stress in HT22 hippocampal cells

418

Neuroprotective Consequences of Postconditioning on Embolic Model of Cerebral Ischemia in Rat

419

Neuroprotective Effect of Matricaria chamomilla Extract on Motor Dysfunction Induced by Transient Global Cerebral Ischemia and Reperfusion in Rat

420

Neuroprotective Effect of 4T1 and Sertoli Cells CoTransplantation in Animal Model of Brain Ischemia

421

Neuroprotective effect of Acorus calamus Linn. extract on a rat model of chronic constriction injury of median nerve-induced peripheral neuropathy

422

Neuroprotective effect of ACTH (4-9) in degeneration of hippocampal nerve cells caused by dexamethasone: morphological, immunocytochemical and ultrastructural studies

423

Neuroprotective effect of agmatine in rats with transient cerebral ischemia using MR imaging and histopathologic evaluation

424

Neuroprotective effect of alkyl hydroxytyrosyl ethers in rat brain slices subjected to a hypoxia-reoxygenation model

425

Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia

426

Neuroprotective effect of blackberry (Rubus sp.) polyphenols is potentiated after simulated gastrointestinal digestion

427

Neuroprotective Effect of Celastrus Paniculatus Seed Extract on Epilepsy and Epilepsy-associated Cognitive Deficits

428

Neuroprotective Effect of Coenzyme Q10 in Chronic Constriction Injury-Induced Neuropathic Pain in Rat

429

Neuroprotective effect of Coenzyme Q10 in hippocampal injury in Balb/c mouse

430

Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein

431

Neuroprotective Effect of DAHP via Antiapoptosis in Cerebral Ischemia

432

Neuroprotective effect of Decalepis hamiltonii roots against ethanol-induced oxidative stress

433

Neuroprotective effect of dimethyl fumarate in stroke: The role of nuclear factor erythroid 2-related factor 2

434

Neuroprotective Effect of Erythropoietin in Postoperation Cervical Spinal Cord Injury: Case Report and Review

435

Neuroprotective effect of ethanolic leaf extract of Commiphora caudata (Wight Arn) against lipopolysaccharide-induced neurotoxicity in Wistar rats

436

Neuroprotective Effect of Exogenous Melatonin on Dopaminergic Neurons of the Substantia Nigra in Ovariectomized Rats

437

Neuroprotective effect of geraniol and curcumin in an acrylamide model of neurotoxicity in Drosophila melanogaster: Relevance to neuropathy

438

Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats

439

Neuroprotective effect of hexasulfobutylated C60 on rats subjected to focal cerebral ischemia

440

Neuroprotective effect of Launaea taraxacifolia against neuroinflammation, memory loss and neurobehavioral deficit in a rat model of hypertension: biochemical and immunohistochemical approaches

441

Neuroprotective effect of L-deprenyl on the expression level of the Mst1 gene and inhibition of apoptosis in rat-model spinal cord injury

442

Neuroprotective effect of melatonin in a rat model ofstreptozotocin-induced diabetic neuropathy: Light andelectron microscopic study

443

Neuroprotective Effect of Melatonin in the Hippocampus of Rat’s Brain in Normal Aging Model

444

Neuroprotective Effect of Melatonin on Brain Damage Induced by Acute Global Cerebral Ischemia in Cats

445

Neuroprotective effect of memantine on serum S100-B levels after on-pump coronary artery bypass graft surgery: A randomized clinical trial

446

Neuroprotective effect of methanolic extract of Sargassum wightii on rotenone-induced parkinsonism-like symptoms in Wistar albino rats

447

Neuroprotective Effect of Paroxetine on Memory Deficit Induced by Cerebral Ischemia after Transient Bilateral Occlusion of Common Carotid Arteries in Rat

448

Neuroprotective effect of p-coumaric acid in rat model of embolic cerebral ischemia

449

Neuroprotective Effect of Pentoxifylline on 3,4-Methylenedioxymethamphetamine-Induced Apoptosis in CA1 Cells of Wistar Rat Hippocampus

450

Neuroprotective Effect of Quercetin Encapsulated Liposomes: A Novel Therapeutic Strategy against Alzheimerʹs Disease

451

Neuroprotective Effect of Quercetin in a Model of Parkinson’s Disease in Rat: A histochemical Analysis

452

Neuroprotective effect of selective antegrade cerebral perfusion during prolonged deep hypothermic circulatory arrest: Cerebral metabolism evidence in a pig model

453

Neuroprotective effect of thymoquinone in acrylamide-induced neurotoxicity in Wistar rats

454

Neuroprotective Effect of Thymoquinone, the Nigella Sativa Bioactive Compound, in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rat Model

455

Neuroprotective Effect of Total and Sequential Extract of Scrophularia striata Boiss. in Rat Cerebellar Granule Neurons Following Glutamate- Induced Neurotoxicity: An In-vitro Study

456

NEUROPROTECTIVE EFFECT OF VITAMIN C AGAINST PTZ INDUCED APOPTOTIC NEURODEGENERATION IN ADULT RAT BRAIN

457

Neuroprotective effect of water lily (Nymphaea pubescens Willd) seed ethanolic extract against trimethyltin-induced cognitive impairment and neurodegeneration in mice

458

Neuroprotective Effect of Zataria Multiflora Essential Oil on Rats With Alzheimer Disease: A Mechanistic Study

459

Neuroprotective Effects of 1,8-Cineole on Apoptosis Inhibition and Bcl-2/Caspase-3 mRNA Expression in the Hippocampus of Epileptic Pilocarpine Model Rats

460

Neuroprotective Effects of Acetyl-l-Carnitine After Stroke in Rats, , ,

461

Neuroprotective effects of alpha-lipoic acid on radiation-induced brainstem injury in rats

462

Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats

463

Neuroprotective Effects of Berberine Hydrochloride on Methamphetamine-induced Cognitive Dysfunction: Immunohistochemical and Behavioral Studies in Rats

464

Neuroprotective Effects of Bone Marrow Mesenchymal Stem Cells on Bilateral Common Carotid Arteries Occlusion Model of Cerebral Ischemia in Rat

465

Neuroprotective effects of caffeine against beta-amyliod neurotoxicity: The involvement of glycogen synthase kinase-3β protein

466

Neuroprotective Effects of Carnosic Acid in an Experimental Model of Alzheimer’s disease in Rats

467

Neuroprotective effects of carvacrol against Alzheimer’s disease and other neurodegenerative diseases: A review

468

Neuroprotective effects of celastrol on sciatic nerve transection model in male Wistar rats

469

Neuroprotective Effects of Chrysin Mediated by Estrogenic Receptors Following Cerebral Ischemia and Reperfusion in Male Rats

470

Neuroprotective effects of cobalt ferrite nanoparticles coated with sumac on damaged sciatic nerve recovery

471

Neuroprotective effects of cognitive enrichment

472

Neuroprotective Effects of Combined Treatment with Minocycline and Olfactory Ensheathing Cells Transplantation against Inflammation and Oxidative Stress after Spinal Cord Injury

473

Neuroprotective effects of Coriandrum sativum and its constituent, linalool: A review

474

Neuroprotective effects of crocin on the histopathological alterations following brain ischemia-reperfusion injury in rat

475

Neuroprotective effects of curculigoside against NMDA-induced neuronal excitoxicity in vitro

476

Neuroprotective Effects of Curcumin Against Transient Global Ischemia are Dose and Area Dependent

477

Neuroprotective Effects of Curcumin on the Proliferation and Viability of Neural Stem Cells against H2O2

478

Neuroprotective effects of cystamine in aged parkinsonian mice

479

Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinsonʹs Disease

480

Neuroprotective Effects of Epigallocatechin-3-Gallate in an Experimental Model of Alzheimer’s Disease in Rat: A Histological Study

481

Neuroprotective effects of Equisetum telmateia in rat

482

Neuroprotective effects of Eriobotrya japonica against β-amyloid-induced oxidative stress and memory impairment

483

Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke

484

Neuroprotective Effects of Exercise on Brain Edema and Neurological Movement Disorders Following the Cerebral Ischemia and Reperfusion in Rats

485

Neuroprotective Effects of Fe3O4 Nanoparticles Coated with Omega-3 as a Novel Drug for Recovery of Sciatic Nerve Injury in Rats

486

Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells

487

Neuroprotective effects of gallic acid in a rat model of traumatic brain injury: behavioral, electrophysiological, and molecular studies

488

Neuroprotective Effects of Herbal Extract (Rosa canina, Tanacetum vulgare and Urtica dioica) on Rat Model of Sporadic Alzheimer’s Disease

489

Neuroprotective effects of intense training and thyme honey on hippocampal cognitive pathways in diabetic rats

490

Neuroprotective Effects of Isoquercetin: An In Vitro and In Vivo Study

491

Neuroprotective effects of kobophenol A against the withdrawal of tropic support, nitrosative stress, and mitochondrial damage in SH-SY5Y neuroblastoma cells

492

Neuroprotective Effects of Medicinal Plants and Their Constituents on Different Induced Neurotoxicity Methods: A Review

493

Neuroprotective Effects of Memantine in the Retina of Glaucomatous Rats: An Electron Microscopic Study

494

Neuroprotective effects of naturally occurring biflavonoids

495

Neuroprotective effects of neolignans isolated from Magnoliae Cortex against glutamate-induced apoptotic stimuli in HT22 cells

496

Neuroprotective Effects of Normobaric Hyperoxia and Transplantation of Encapsulated Choroid Plexus Epithelial Cells on The Focal Brain Ischemia

497

Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats

498

Neuroprotective effects of Pinus eldarica in a mouse model of pentylenetetrazole-induced seizures

499

Neuroprotective Effects of Pramipexole in Parkinson s Disease Induced by Rotenone in Mice

500

Neuroprotective Effects of Progesterone on Damage Elicited by Acute Global Cerebral Ischemia in Neurons of the Caudate Nucleus

501

Neuroprotective effects of propolis and caffeic acid phenethyl ester (CAPE) on the radiation-injured brain tissue (Neuroprotective effects of propolis and CAPE)

502

Neuroprotective effects of resveratrol on embryonic dorsal root ganglion neurons with neurotoxicity induced by ethanol

503

Neuroprotective effects of rosemary extract on white matter of prefrontal cortex in old rats

504

Neuroprotective effects of Salvia aristata Aucher ex Benth. on hydrogen peroxide induced apoptosis in SH-SY5Y neuroblastoma cells

505

Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague–Dawley rats

506

Neuroprotective effects of selenium and ginkgo biloba extract (EGb761) against ischemia and reperfusion injury in rat brain

507

Neuroprotective Effects of Semaglutide in Endotoxemia Mouse Model

508

Neuroprotective effects of silymarin on sodium fluoride-induced oxidative stress

509

Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering

510

Neuroprotective effects of Tacca chantrieri Andre against lipopolysaccharide-induced cognitive impairment and neuroinflammation

511

Neuroprotective effects of Tiliacora triandra leaf extract in a mice model of cerebral ischemia reperfusion

512

Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE

513

Neuroprotective Effects of Vitamin D on Patients With Traumatic Brain Injury: A Clinical Trial

514

Neuroprotective Effects of Vitexin and Cajanus cajan Extract Against Pb-induced Neurotoxicity in Wistar Rats

515

Neuroprotective effects of voluntary wheel running and eriobotrya japonica flower extract on Parkinsonian rats

516

Neuroprotective effects of walnut (Juglans regia L.) in nervous system disorders: A comprehensive review

517

Neuroprotective effects of Wharton’s jelly-derived mesenchymal stem cells on motor deficits due to Parkinson’s disease

518

Neuroprotective effects of Withania coagulans root extract on CA1 hippocampus following cerebral ischemia in rats

519

Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment

520

Neuroprotective effects of Z-ajoene, an organosulfur compound derived from oil-macerated garlic, in the gerbil hippocampal CA1 region after transient forebrain ischemia

521

Neuroprotective effects of α-lipoic acid and its positively charged amide analogue

522

Neuroprotective gene profile in the brain of magnesium-deficient mice

523

Neuroprotective mechanism of bromocriptine

524

Neuroprotective or neurotoxic activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline and related compounds

525

Neuroprotective Plants; What, How, an‎d Why? A Narrative Review

526

Neuroprotective potential of some terebinth coffee brands and the unprocessed fruits of Pistacia terebinthus L. and their fatty and essential oil analyses

527

Neuroprotective Potential of Trans-Anethole Following Crush Injury of the Sciatic Nerve in Rats

528

Neuroprotective Properties of Melissa Officinalis L. Extract Against Ecstasy-Induced Neurotoxicity

529

Neuroprotective properties of Melissa officinalisafter hypoxic-ischemic injury both in vitro and in vivo

530

Neuroprotective Properties of Photobiomodulation in Retinal Regeneration in Rats: Perspectives From Interaction Levels

531

Neuroprotective properties of Spanish red wine and its isolated polyphenols on astrocytes

532

Neuroprotective role of curcumin on the hippocampus against the structural and serological alterations of streptozotocin-induced diabetes in Sprague Dawely rats

533

Neuroprotective role of vitamin D3 in colchicine-induced Alzheimer’s disease in rats

534

Neuroprotective roles of flavonoid “hispidulin” in the central nervous system: A review

535

Neuroprotective Strategies in the Perioperative Period: A Systematic Review

536

Neuroprotective therapy for acute ischaemic stroke: down, but not out

537

Neuroprotective Treatment With FK506 Reduces Hippocampal Damage and Prevents Learning and Memory Deficits After Transient Global Ischemia in Rat

538

Neuroprotective, antimicrobial, antioxidant, chemotherapeutic, and antidiabetic properties of Salvia Reuterana: A mini review

539

Neuroproteomics comes of age

540

Neuropsychiaric perspective and recommendations

541

Neuropsychiatric and neuropsychological manifestations of central pontine myelinolysis

542

Neuropsychiatric and Psychosocial Issues of Patients With Hepatitis C Infection: A Selective Literature Review

543

Neuropsychiatric aspects in Munchausenʹs syndrome

544

Neuropsychiatric aspects of epilepsy in children

545

Neuropsychiatric aspects of patients with hypothalamic hamartomas

546

Neuropsychiatric changes after liver transplantation

547

Neuropsychiatric Complications Following Liver Transplantation

548

NEUROPSYCHIATRIC COMPLICATIONS IN LIVER TRANSPLANT PATIENTS IN A TERTIARY HOSPITAL IN SINGAPORE

549

Neuropsychiatric Complications of COVID-19: What is to be Expected

550

Neuropsychiatric effects of medications for allergic diseases

551

Neuropsychiatric features of systemic lupus erythematosus

552

Neuropsychiatric Function and Dehydroepiandrosterone Sulfate in Elderly Women: A Prospective Study

553

Neuropsychiatric Illness: A Case for Impaired Neuroplasticity and Possible Quantum Processing Derailment in Microtubules

554

Neuropsychiatric implications of basal ganglia dysfunction

555

Neuropsychiatric Lupus

556

Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests,

557

Neuropsychiatric Manifestations in a Patientwith Panhypopituitarism

558

Neuropsychiatric Manifestations of COVID-19 in Hospitalized Pediatrics: A Multicenter Cross-sectional Study

559

Neuropsychiatric Manifestations of Partial Agenesis ofthe Corpus Callosum: A Case Report and Literature Review

560

Neuropsychiatric perspectives on nodding syndrome in northern Uganda: a case series study and a review of the literature

561

Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate

562

Neuropsychiatric reaction induced by abacavir

563

Neuropsychiatric reactions with mefloquine chemoprophylaxis

564

Neuropsychiatric sequelae in a case of St. Louis Encephalitis

565

Neuropsychiatric Symptoms As The First Manifestation of Juvenile Systemic Lupus Erythematosus: A Complicated Case With Klinefelterʹʹs Syndrome

566

Neuropsychiatric Syndromes and Occupational Exposure to Zinc Phosphide in Egypt

567

Neuropsychiatric systemic lupus erythematosus: Correlation of brain MR imaging, CT, and SPECT

568

Neuropsychiatric toxicity of Ifosfamide in patients admitted for chemotherapy

569

Neuropsychiatry and Behavioral Neuroscience

570

Neuropsychiatry in old age : by C. Stefanis and H. Hippius, 1996, Hogrefe & Huber Publishers, Seattle, USA, 171 pages, US$ 32, ISBN 0-88937-137-7

571

Neuropsychiatry, second edition.R.B. Schiffer, S.M. Roa and B.S. Fogel, Editors, Lippincott Williams & Wilkins, Philadelphia (2003) $169, 1312 pages.

572

Neuropsychiatry—a discipline for the future

573

Neuropsychiatryʹs offspring

574

Neuropsychiatry—The mind embrained?

575

Neuro-Psychoanalysis May Enliven the Mindbrain Sciences

576

Neuropsychologic and Functional Recovery From Severe Carbon Monoxide Poisoning Without Hyperbaric Oxygen Therapy, , ,

577

Neuropsychologic Changes After Coronary Artery Bypass Grafting: Use of Reliable Change Indices

578

Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading

579

Neuropsychologic Impairment in Patients with Nonepileptic Seizures

580

Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery

581

Neuropsychologic Theory and Findings in Attention-Deficit/Hyperactivity Disorder: The State of the Field and Salient Challenges for the Coming Decade

582

Neuropsychological abnormalities in cirrhosis include learning impairment

583

Neuropsychological and anatomical correlates of E4 in Alzheimerʹs disease

584

Neuropsychological and behavioral disorders as presentation symptoms in two brothers with early-infantile Niemann-Pick type C

585

Neuropsychological and cognitive psychophysiological substrates of impulsive aggression

586

Neuropsychological and Diagnostic Differences Between Recidivistically Violent Not Criminally Responsible and Mentally Ill Prisoners

587

Neuropsychological and emotional changes during simulated microgravity: effects of triiodothyronine, alendronate, and testosterone

588

Neuropsychological and Emotional Functioning in Patients with Cushing's Syndrome

589

Neuropsychological and mood effects of ketamine in electroconvulsive therapy: A randomised controlled trial

590

Neuropsychological and neurological correlates in an elderly rural population

591

Neuropsychological and neurophysiological deficits in extremely high velocity traumatic brain injury: A case report

592

Neuropsychological and Neuropsychiatric Deficits Following Traumatic Brain Injury: Common Patterns and Neuropathological Mechanisms

593

Neuropsychological and psychiatric changes after deep brain stimulation for Parkinsonʹs disease: a randomised, multicentre study

594

Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: A comparative short-term study

595

Neuropsychological and QEEG assessment of adult ADHD

596

Neuropsychological aspects of chronic relapsing pancreatitis: A longitudinal case study

597

Neuropsychological aspects of epilepsy surgery

598

Neuropsychological aspects of Tourette syndrome: A review

599

Neuropsychological aspects of type of epilepsy and etiological factors in adults

600

Neuropsychological assessment and volumetric magnetic resonance imaging of the corpus callosum in dementia

601

Neuropsychological Assessment In Epilepsy Surgery – Preliminary Experience In A Rural Tertiary Care Hospital In North East Malaysia

602

Neuropsychological assessment in patients evaluated for hyperthermia for metastatic nonsmall lung carcinoma (FDA phase 1 and phase 2)

603

Neuropsychological assessment of a rare systemic vascular disorder: a case study of Rendu—Osler—Weber syndrome

604

Neuropsychological Assessment of Organic Solvent Effects in South Africa: Test Selection, Adaptation, Scoring, and Validation Issues

605

Neuropsychological assessment of persons with physical disability, visual impairment or blindness, and hearing impairment or deafness

606

Neuropsychological assessment of relatively intact individuals: Psychometric lessons from an HIV+ sample

607

Neuropsychological assessment of the blind and visually impaired

608

Neuropsychological assessments before and aftertreatment in patients with anorexia nervosa and bulimianervosa

609

Neuropsychological change following gamma knife surgery in patients with left temporal lobe epilepsy: a review of three cases

610

Neuropsychological changes and treatment compliance in older adults with sleep apnea

611

Neuropsychological Changes in Complex Regional Pain Syndrome (CRPS)

612

Neuropsychological characterization of hepatic encephalopathy

613

Neuropsychological complaint base rates in personal injury, revisited

614

Neuropsychological consequences of bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinsonʹs disease: A 1-year longitudinal follow-up

615

Neuropsychological consequences of HIV in children: A review of current literature

616

Neuropsychological consequences of right thalamic haemorrhage: Case study and review

617

Neuropsychological consequences of sequential concussions in a female college basketball player

618

Neuropsychological correlates between working memory and executive functioning

619

Neuropsychological correlates of adjunct therapy with a nutritional/vitamin supplement in a medical patient sample

620

Neuropsychological Correlates of Community Function among Major Depressive Disorder Outpatients without Comorbidity in Hong Kong: An Exploratory Cross‑Sectional Study

621

Neuropsychological correlates of dominance, warmth, and extraversion in neurodegenerative disease

622

Neuropsychological correlates of Gulf War syndrome

623

Neuropsychological correlates of homocysteine levels in euthymic bipolar patients

624

Neuropsychological Correlates of Methylphenidate Treatment in Adult ADHD With and Without Depression

625

Neuropsychological correlates of opioid dependence and withdrawal

626

Neuropsychological correlates of psychopathic traits in a non-incarcerated sample

627

Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis

628

Neuropsychological correlates of self-reported impulsive aggression in a college sample

629

Neuropsychological correlates of violence and aggression: A review of the clinical literature

630

Neuropsychological decline following herpes zoster without encephalitis: A case study

631

Neuropsychological Decomposing Stroop Interference Into Different Cognitive Monitoring: An Exploratory Factor Analysis

632

Neuropsychological deficit profiles in senile dementia of the Alzheimerʹs type

633

Neuropsychological deficits among patients with late-onset minor and major depression

634

Neuropsychological deficits associated with chronic hepatitis C among male veterans

635

Neuropsychological deficits in bipolar depression persist after successful antidepressant treatment

636

Neuropsychological deficits in marijuana smokers

637

Neuropsychological deficits in probands from multiply-affected schizophrenic families

638

Neuropsychological deficits of patients with chronic or acute cerebellar lesions

639

Neuropsychological developmental change in a case with Noonan syndrome: longitudinal assessment

640

Neuropsychological Disorders in Patients with Brain Tumor

641

Neuropsychological dissociations between motion and form perception suggest functional organization in extrastriate cortical regions in the human brain

642

Neuropsychological double dissociation between linguistic levels: Clinical linguistic evidence from Iranian aphasic patients

643

Neuropsychological dysfunction after minimally invasive direct coronary artery bypass grafting

644

Neuropsychological Dysfunction in Children with Borderline Personality Disorder Features: A Preliminary Investigation

645

Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease

646

Neuropsychological dysfunction in patients with end-stage pulmonary disease: Lung transplant evaluation

647

Neuropsychological dysfunction in patients with end-stage pulmonary disease: lung transplant evaluation

648

Neuropsychological dysfunction in schizotypal personality disorder: A profile analysis

649

Neuropsychological Effects of Chronic Exposure to Environmental Dioxins and Furans

650

Neuropsychological effects of epilepsy and antiepileptic drugs

651

Neuropsychological effects of exposure to sheep dip

652

Neuropsychological effects of long-term exposure to organophosphates in sheep dip

653

Neuropsychological effects of seizures

654

Neuropsychological effects of stress on social phobia with and without comorbid depression

655

Neuropsychological evaluation in rehabilitation planning and evaluation of functional skills

656

Neuropsychological evaluation in the diagnosis and management of sports-related concussion

657

Neuropsychological Evaluation of Older Children : By Ralph M. Reitan and Deborah Wolfson, South Tucson, AZ: Neuropsychology Press, 1992. + 814 pp

658

Neuropsychological evidence for dimensional schizotypy: Implications for creativity and psychopathology

659

Neuropsychological exploration of alleged mold neurotoxicity

660

Neuropsychological explorations of memory and cognition: Essay in honor of Nelson butters :Eidted by Laird S. Cermak, N ew York: Plenum Press, 1994.

661

Neuropsychological features of diffuse Lewy body disease

662

Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation

663

Neuropsychological findings in adult attention deficit disorder

664

Neuropsychological findings in young-adult stroke patients

665

Neuropsychological follow-up of high risk infants at school age: Wechsler Verbal-Performance discrepancies

666

Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimers disease

667

Neuropsychological function and psychosocial status of alcohol rehabilitation program residents

668

Neuropsychological function in adults with attention-deficit hyperactivity disorder

669

Neuropsychological function in female victims of intimate partner violence with and without posttraumatic stress disorder

670

Neuropsychological function in unmedicated recurrent brief depression

671

Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson’s disease

672

Neuropsychological functioning in a subclinical obsessive-compulsive sample

673

Neuropsychological Functioning in Adolescent Children of Mothers with a History of Bipolar or Major Depressive Disorders

674

Neuropsychological functioning in adult insulin-dependent diabetes mellitus (IDDM) patients

675

Neuropsychological Functioning in Bipolar Disorder and Schizophrenia

676

Neuropsychological functioning in chronic lyme disease: The role of mental effort

677

Neuropsychological Functioning in Danish Gulf War Veterans

678

Neuropsychological functioning in depressed adolescent girls

679

Neuropsychological functioning in kleptomania

680

Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants

681

Neuropsychological Functioning in Migraine Headache, Nonheadache Chronic Pain, and Mild Traumatic Brain Injury Patients

682

Neuropsychological Functioning in Obsessive-Compulsive Washers: Drug-Naive Without Depressive Symptoms

683

Neuropsychological functioning in people with ADHD across the lifespan

684

Neuropsychological functioning in sons of active alcoholic, recovering alcoholic, and social drinking fathers

685

Neuropsychological functioning in trichotillomania

686

Neuropsychological functioning in two brothers with X-linked adrenoleukodystrophy: A longitudinal case study of phenotypic variation and bone marrow transplant outcome

687

Neuropsychological Functioning in Youth with Bipolar Disorder

688

Neuropsychological functioning of children and adolescents with conduct disorder and aggressive-assaultive features

689

Neuropsychological functioning of dementia patients with psychosis

690

Neuropsychological Functioning of Inmates Referred for Psychiatric Treatment

691

Neuropsychological Functioning: Comparison of Mothers at High- and Low-Risk for Child Physical Abuse

692

Neuropsychological functions and the BASC

693

Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction

694

Neuropsychological impairment after hemorrhagic stroke in basal ganglia

695

Neuropsychological impairment associated with compulsive hoarding

696

Neuropsychological impairment in fibromyalgia: Relation to depression, fatigue, and pain

697

Neuropsychological information in the Wechsler adult intelligence scale—revised

698

Neuropsychological Interventions: Clinical Practice and Research: By Paul J. Eslinger. New York: The Guilford Press, 2002, 359 pages

699

Neuropsychological Manifestation in Ebola: A Concern

700

Neuropsychological measures probably facilitate heritability research of ADHD

701

Neuropsychological outcome and quantitative neuroimaging in mild head injury,

702

Neuropsychological Outcome and the Extent of Resection in the Unilateral Temporal Lobectomy

703

Neuropsychological outcome following focal cortical removal for intractable epilepsy in children

704

Neuropsychological Outcome following Resuscitation after Out-of-Hospital Cardiac Arrest: A One-Year Follow-Up

705

Neuropsychological Outcome in Children after Frontal Lobe Epilepsy Surgery

706

Neuropsychological Outcome of Head Injury Using a Short Battery

707

NEUROPSYCHOLOGICAL OUTCOMES OF NOCTURNAL ASTHMA

708

Neuropsychological outcomes of pediatric burn patients who sustained hypoxic episodes

709

Neuropsychological parameters of pediatric migraineurs and tensioneurs

710

Neuropsychological performance deficits in adults with attention deficit/hyperactivity disorder

711

Neuropsychological performance in a sample of 13–25 year olds with a history of non-psychotic major depressive disorder

712

Neuropsychological performance in adult attention-deficit hyperactivity disorder: Meta-analysis of empirical data

713

Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: A longitudinal, naturalistic study

714

Neuropsychological Performance in Children and Adolescents with Obsessive-Compulsive Disorder and Influence of Clinical Variables

715

Neuropsychological Performance in First-Episode Adolescents with Schizophrenia: A Comparison with First-Episode Adults and Adolescent Control Subjects

716

Neuropsychological performance in gravesʹ hyperthyroidism: Evidence for executive dysfunction

717

Neuropsychological Performance in Gulf War Era Veterans: Motivational Factors and Effort

718

Neuropsychological Performance in Gulf War Era Veterans: Neuropsychological Symptom Reporting

719

Neuropsychological Performance in Gulf War Era Veterans: Traumatic Stress Symptomatology and Exposure to Chemical–Biological Warfare Agents

720

Neuropsychological performance in men and women at risk for hypertension

721

Neuropsychological performance in normal pregnancy and preeclampsia

722

Neuropsychological performance in pediatric bipolar disorder

723

Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity

724

Neuropsychological performance of a clinical sample of extremely obese individuals

725

Neuropsychological Performance of Adults Evidencing Attention-Deficit Hyperactivity Disorder

726

Neuropsychological performance of monozygotic twins discordant for bipolar disorder

727

Neuropsychological Performance Over Time in People at High Risk of Developing Schizophrenia and Controls

728

Neuropsychological performance predicts clinical recovery in bipolar patients

729

Neuropsychological predictors of adaptive living and work behaviors

730

Neuropsychological predictors of emotional prosody: Implications for hemispheric asymmetry

731

Neuropsychological Profile at Three Months Post Injury in Patients with Traumatic Brain Injury

732

Neuropsychological profile in patients with obsessive-compulsive disorder over a period of 4-month treatment

733

Neuropsychological Profile of a Large Kindred with Familial Alzheimerʹs Disease Caused by the E280A Single Presenilin-1 Mutation

734

Neuropsychological profile of patients with juvenile myoclonic epilepsy: A controlled study of 50 patients

735

Neuropsychological profile of prodromal Alzheimerʹs disease (Prd-AD) and their radiological correlates

736

Neuropsychological Profiles Associated with Subcortical White Matter Alterations and Parkinsonʹs Disease:: Implications for the Diagnosis of Dementia

737

Neuropsychological profiles of children diagnosed as specific language impaired with and without hyperlexia

738

Neuropsychological recovery from childhood moyamoya disease

739

Neuropsychological Sequelae in a Series of Patients with End-Stage Cystic Fibrosis: Lung Transplant Evaluation

740

Neuropsychological sequelae in subacute home chlordane poisoning: Ten case studies

741

Neuropsychological Similarities and Differences Among Huntington’s Disease, Multiple Sclerosis, and Cortical Dementia

742

Neuropsychological Studies of Late Onset and Subthreshold Diagnoses of Adult Attention-Deficit/Hyperactivity Disorder

743

Neuropsychological study of ciguatera fish poisoning: A longitudinal case-control study

744

Neuropsychological Test Development and Normative Data on Hispanics

745

Neuropsychological test performance and prediction of functional capacities among Spanish-speaking and English-speaking patients with dementia

746

Neuropsychological test performance in a cognitively intact sample of older Japanese American adults

747

Neuropsychological Test Performance in Illiterate Subjects

748

Neuropsychological test performance of children with ADHD relative to test norms and parent behavioral ratings

749

Neuropsychological Test Performances of Young Depressed Outpatient Women: An Examination of Executive Functions

750

Neuropsychological testing defines the neurobehavioral significance of neuroimaging-identified abnormalities

751

Neuropsychological testing of adults: further considerations for neurologists

752

Neuropsychological testing of high school athletes: Preliminary norms and test–retest indices

753

Neuropsychological tests and SPECT in dementing disorders

754

Neuropsychological tests predict independent activities of daily living in patients with dementia

755

Neuropsychological toxicology: Identification and assessment of human neurotoxic syndromes : Second Edition, by David E. Hartman. New York: Plenum Press, 1995. 429 pp, $59.50 hardcover

756

Neuropsychological, Neuroanatomical, and Neurophysiological Consequences of CNS Chemotherapy for Acute Lymphoblastic Leukemia

757

Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia

758

Neuropsychologistsʹ Practice Patterns in Assessing Premorbid Intelligence

759

Neuropsychologists’ abilities to determine the predictive value of diagnostic tests

760

Neuropsychology and linguistic aphasiology: Evidence in favor of case studies

761

Neuropsychology is nothing without control: A potential fallacy hidden in clinical studies

762

Neuropsychology of Alzheimerʹs Disease

763

Neuropsychology of bipolar disorder: a review

764

Neuropsychology of BPI and BPII

765

Neuropsychology of BPI and BPII

766

Neuropsychology of BPI and BPII

767

Neuropsychology of developmental stuttering

768

Neuropsychology of dual diagnosis: Understanding the combined effects of schizophrenia and substance use disorders

769

Neuropsychology of obsessive-compulsive disorder: a review and treatment implications

770

Neuropsychology of timing and time perception

771

Neuropsychology, the Patientʹs Experience, and the Political Forces Within Our Field

772

Neuroptera in agricultural ecosystems

773

Neuropteran (Insecta) palaeodiversity with predictions for the Cretaceous fauna of the Wealden

774

Neuroradiologic MR applications with multiparametric color composite display

775

Neuroradiological assessment of brain structure and function and its implication in the pathogenesis of West syndrome

776

Neuroradiological findings in primary cerebral lymphomas of non-AIDS patients

777

Neuroradiology of spine degenerative diseases

778

Neuroreceptor subunit genes and the genetic susceptibility to gilles de la tourette syndrome

779

Neurorehabilitation, the Practical Method of Returning to Work after Stroke

780

Neurorehabilitation: no more constraint for large randomised trials

781

Neuroretinal function is normal in early dementia of the Alzheimer type

782

Neurosarcoidosis

783

Neurosarcoidosis presenting as a large suprasellar mass: Magnetic resonance imaging findings

784

Neurosarcoidosis presenting with simple partial seizures and solitary enhancing mass: case reports and review of the literature

785

Neurosarcoidosis: a clinical dilemma

786

Neurosarcoidosis: a treatable cause of vestibular dysfunction

787

Neurosarcoidosis: Findings in MRI

788

Neuroscience and computing algorithms

789

Neuroscience and the soul: Competing explanations for the human experience

790

Neuroscience approach in Stem cell therapy among patients with Spinal Cord Injury

791

Neuroscience as an Insightful Decision Support Tool for Sustainable Development

792

Neuroscience meets dance/movement therapy: Mirror neurons, the therapeutic process and empathy

793

Neuroscience output of China: A MEDLINE-based bibliometric study

794

Neuroscience research on the addictions: A prospectus for future ethical and policy analysis

795

Neuroscience, neuroimaging and the law

796

Neuroscience, quantum indeterminism and the Cartesian soul

797

Neuroscience: Where is it heading?: Some reflections on the future of brain research at the end of the second millenium

798

Neuroscience-Informed Psychoeducation for Recovery: A Program to Promote Metacognition in People With Substance Use Disorders

799

Neurosciences Quiz: Subclinical rhythmic electrographic discharges of adults (SREDA): Case Presentation

800

Neurosciences, psychiatrie et psychopathologie : quelles évolutions pour la relation clinique ?

801

Neuroscientific challenges to free will and responsibility

802

Neuroscientists discover disgusting regions of the brain

803

Neuroscientists hear impassioned plea from Superman

804

Neuroscientists take a BOLD step forward

805

Neuro-Second Order Sliding Mode Control of a DFIG Supplied by a Two-Level NSVM Inverter for Wind Turbine System

806

Neurosensory changes of palatal mucousa following Le Fort I osteotomy

807

Neuro-short-term load forecast of the power system in Kuwait

808

Neuro-simulation analysis of pressure maintenance operations in gas condensate reservoirs

809

Neuro-simulation modeling of chemical flooding

810

Neurosolver: Neuromorphic general problem solver

811

Neurosphere-Free Transdifferentiation of Rat Bone Marrow Stromal Stem Cells Into Retinal Cells and Retinal Pigment Epithelium

812

Neurospora crassa CyPBP37: A Cytosolic Stress Protein that is able to Replace Yeast Thi4p Function in the Synthesis of Vitamin B1

813

Neurospora crassa FKBP22 Is a Novel ER Chaperone and Functionally Cooperates with BiP

814

Neurosteroid analogues. Part 13: Synthetic methods for the preparation of 2β-hydroxygonane derivatives as structural mimics of ent-3α-hydroxysteroid modulators of GABAA receptors

815

Neurosteroid analogues: synthesis of 6-aza-allopregnanolone

816

Neurosteroid analysis by gas chromatography–atmospheric pressure photoionization–tandem mass spectrometry Original Research Article

817

Neurosteroid dehydroepiandrosterone attenuates 6-hydroxydopamine-induced apoptosis in a cell model of Parkinson's disease

818

Neurosteroids in Rat Brain: Extraction, Isolation, and Analysis by Nanoscale Liquid Chromatography-Electrospray Mass Spectrometry

819

Neurosteroids: 7-aza-allopregnanolone—a poor substitute for allopregnanolone

820

Neurostimulation as a Putative Method for the Treatment of Drug-resistant Epilepsy in Patient and Animal Models of Epilepsy

821

Neurosurgeons report gains in treatment of vascular malformations

822

Neurosurgeons wake up to awake-brain surgery

823

Neurosurgery 7000 years ago in central Italy

824

Neurosurgery in a cold climate

825

Neurosurgery Practice During the COVID-19 Pandemic

826

Neurosurgical Approaches in Demyelinating Disorders; Where are We Now?

827

Neurosurgical Care of Nonpowder Firearm Injuries: A Narrative Review of the Literature

828

Neurosurgical Development in the East, Central and Southern African (ECSA) Region

829

Neurosurgical emergencies, volumes I and II : Christopher Loftus, MD, editor. American Association of Neurological Surgeons, 1994

830

Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I Trial, , , ,

831

NEUROSURGICAL IN-PATIENT PROFILE:A THREE-YEAR AUDIT IN A REGIONAL CENTRE

832

Neurosurgical management of pain: by Richard B. North and Robert M. Levy, Springer Verlag, New York, 1997, ISBN 0-387-94256-4

833

Neurosurgical Operating Room Nurse’s Roles and Responsibilities

834

Neurosurgical procedures for refractory OCD

835

Neurosurgical Procedures in Jehovah’s Witnesses: The Tema Experience

836

Neurosurgical treatment for Gilles de la Tourette syndrome: The Italian perspective

837

Neurosyphilis presenting as refractory status epilepticus

838

Neurosyphilis with Hydrocephalus: A Case Report

839

Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders

840

NeuroTheology and Its Convergence with NeuroQuantology

841

Neurotheology: The relationship between brain and religion.

842

Neurotic butterflies in my stomach: The role of anxiety, anxiety sensitivity and depression in functional gastrointestinal disorders

843

Neurotic disorders in the elderly : J. Lindesay (ed.) Oxford University Press, Oxford (1995). xiii + 250 pp. £39.50

844

Neuroticism and academic achievement: the Furneaux Factor as a measure of academic rigour

845

Neuroticism and affective priming: Evidence for a neuroticism-linked negative schema

846

Neuroticism and attachment insecurity as predictors of bereavement outcome

847

Neuroticism and extraversion as predictors of coping styles during early adolescence

848

Neuroticism and extraversion share genetic and environmental effects with negative and positive mood spillover in a nationally representative sample

849

Neuroticism and Fibromyalgia Syndrome: A Systematic Review and Meta-analysis

850

Neuroticism and introversion: A risky combination for disordered eating among a non-clinical sample of undergraduate women

851

Neuroticism and low educational level predict the risk of posttraumatic stress disorder in women after miscarriage or stillbirth

852

Neuroticism and mental health outcomes for long-term unemployed youth attending occupational skills training programs

853

Neuroticism and self-criticism associated with posttraumatic stress disorder in a nationally representative sample

854

Neuroticism and the facilitation of the automatic orienting of attention

855

Neuroticism as a mediator of treatment response to SSRIs in major depressive disorder

856

Neuroticism but not cardiovascular stress reactivity is associated with less longitudinal blood pressure increase

857

Neuroticism predicts normal variability in the number of circulating leucocytes

858

Neuroticism predicts resting frontal EEG asymmetry variability

859

Neuroticism prospectively predicts pain among adolescents: Results from a nationally representative sample

860

Neuroticism, alexithymia and medically unexplained symptoms

861

Neuroticism, alexithymia, negative affect, and positive affect as determinants of medically unexplained symptoms

862

Neuroticism, cognitive ability, and the metabolic syndrome: The Vietnam Experience Study

863

Neuroticism, daily hassles, and depressive symptoms: An examination of moderating and mediating effects

864

Neuroticism, depression, and depression proneness

865

Neuroticism, Life Events and Negative Thoughts in the Development of Depression in Adolescent Girls

866

Neuroticism, preattentive and attentional biases towards threat, and anxiety before and after a severe stressor: a prospective study

867

Neuroticism, psychiatric symptoms and life events

868

Neuroticism: a non-informative marker of vulnerability to psychopathology

869

Neuroticism: moderator or mediator in the relation between locus of control and depression?

870

Neurotics are dissatisfied with life, but not with services. The South Verona Outcome Project 7

871

Neurotolerability of Gadobenate Dimeglumine Evaluation of Brain Dopamine Concentration in Freely Moving Rats by Microdialysis

872

Neurotolerability of Gadobenate Dimeglumine in a Rat Model of Focal Brain Ischemia: EEG Evaluation

873

Neurotological findings in a patient with narrow internal auditory canal: a case report

874

Neurotoxic and hepatotoxic cyanotoxins removal by nanofiltration

875

Neurotoxic Disorders of Organophosphorus Compounds and Their Managements

876

Neurotoxic effect and metabolic responses induced by a mixture of six pesticides on the earthworm Aporrectodea caliginosa nocturna Original Research Article

877

Neurotoxic effect of lead on rats: Relationship to Apoptosis

878

Neurotoxic effect of linamarin in rats associated with cassava (Manihot esculenta Crantz) consumption

879

Neurotoxic Effects of 2,5-Hexanedione on Rapidly Growing Unmyelinated Peripheral Nerve Axons of a Rat Fetus: Dose–Effect Relationship

880

Neurotoxic effects of 25 mg/kg/bodyweight of artemether on the histology of the trapezoid nuclei and behavioural functions in adult male Wistar rats

881

Neurotoxic Effects of Fractionated Diesel Exhausts Following Microinjections in Rat Hippocampus and Striatum

882

Neurotoxic effects of gasoline and gasoline constituents : T. M. Burbacher. Environmental Health Perspectives Supplements, 101(Suppl. 6), 133–141

883

Neurotoxic Effects of Low Level Exposure to Manganese in Human Populations,

884

Neurotoxic Effects of Low-Level Methylmercury Contamination in the Amazonian Basin

885

Neurotoxic effects of neonatal triethyltin (TET) exposure are exacerbated with aging

886

Neurotoxic lesioning of oxytocin-sensing hindbrain neurons attenuates the satiety response to CCK-8

887

Neurotoxic marine poisoning

888

Neurotoxic Syndromes and Occupational Exposure to Solvents

889

Neurotoxicity and Behavioral Alterations Following Subchronic Administration of Aqueous Extract of Erythrophleum Ivorense Stem Bark in Mice

890

Neurotoxicity and Neuroprotective Effects of Polyimides (PI) and Polyphenylenevinylene (PPV) against Hydrogen Peroxide (H2O2)

891

Neurotoxicity and occupational exposure to PCBs

892

Neurotoxicity Associated with Occupational Exposure to Acetone, Methyl Ethyl Ketone, and Cyclohexanone,

893

Neurotoxicity from Airborne Chemicals Around a Superfund Site

894

Neurotoxicity from glutathione depletion is mediated by Cu-dependent p53 activation

895

Neurotoxicity of 1-bromopropane: Evidence from animal experiments and human studies

896

Neurotoxicity of 2-Bromopropane and 1-Bromopropane, Alternative Solvents for Chlorofluorocarbons,

897

Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade

898

Neurotoxicity of Coscinium fenestratum stem, a medicinal plant used in traditional medicine

899

Neurotoxicity of Dextrorphan

900

Neurotoxicity of gadolinium contrast agents for magnetic resonance imaging in rats with osmotically disrupted blood-brain barrier

901

Neurotoxicity of intrathecal local anaesthetics and transient neurological symptoms

902

Neurotoxicity of Manganese Chloride in Neonatal and Adult CD Rats Following Subchronic (21-Day) High-Dose Oral Exposure

903

Neurotoxicity of nitroxyl: Insights into HNO and NO biochemical imbalance

904

Neurotoxicity of pre-incubated alpha-synuclein with neutral nanoliposomes on PC12 and SHSY5Y cell lines

905

Neurotoxicity of tissue plasminogen activator

906

Neurotoxicity studies on sucralose and its hydrolysis products with special reference to histopathologic and ultrastructural changes

907

Neurotoxicological manifestations among drug abusers admitted to Alexandria poison unit and Al-Mamora hospital: prospective study

908

Neurotoxin Botulinum Inserts Apoptotic Effects on Certain Cancer Cell Lines Via Neural Niche of Tumors: A Molecular Study

909

Neurotoxoplasmosios After Rituximab Therapy in Diffused Proliferative Glomerulonephritis Patient

910

NeuroTracker Three-Dimensional Multiple Object Tracking (3D-MOT): A Tool to Improve Concentration and Game Performance among Basketball Athletes

911

Neurotransmission and neuromodulation in the chemosensory carotid body

912

Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake

913

Neurotransmitter amino acid—oxobenzo[f]benzopyran conjugates: synthesis and photorelease studies

914

Neurotransmitter antagonism in management of irritable bowel syndrome

915

Neurotransmitter changes in the pathophysiology of Lesch–Nyhan syndrome

916

Neurotransmitter effect of galanin on the mean plasma concentrations of growth hormone, triiodothyronine, thyroxine, and milk protein in dairy goats sannan

917

Neurotransmitter interactions in schizophrenia—therapeutic implications

918

Neurotransmitter localization in the neuroepithelial cells and unipolar neurons of the respiratory tract in the bichir, Polypterus bichir bichir G. ST-HIL

919

Neurotransmitter receptor alterations in hepatic encephalopathy: A review

920

Neurotransmitters and Neuropeptides in the Developing Human Central Nervous System A Review

921

Neurotransmitters and signal transduction processes in bipolar affective disorders: a synopsis

922

Neurotransmitters and the Behavior of Individual Investors: Exploratory and Confirmatory Factor Analysis

923

Neurotransmitters and vulnerability of the developing brain

924

Neurotransmitters Disorders with Mild Hyperphenylalaninemia: The Ones That Should Not Be Missed

925

Neurotransplantation in Parkinsonʹs disease

926

Neurotrauma as an Evolving Indication for Neuromodulation

927

Neurotrauma Registries in Low- and Middle-Income Countries for Building Organized Neurotrauma Care: The LATINO Registry Experience; Comment on “Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries”

928

Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries

929

Neurotrimin and Syndecan-1 Biomarker Levels in Patients With Decompensated Heart Failure

930

Neurotrimin is an estrogen-inducible, uterine protein that mediates sympathetic axon repulsion

931

Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons

932

Neurotrophic and antileukemic daphnane diterpenoids from Synaptolepis kirkii Original Research Article

933

Neurotrophic corneal defect after diode laer cycloablation

934

Neurotrophic Corneal Ulcer after Topical Tetracaine Abuse: Management Guidelines

935

Neurotrophic Effects of Swimming and Crocin Consumption on the Rats with Obesity Induced by a High-fat Diet

936

Neurotrophic factor linked to Rettʹs syndrome

937

Neurotrophic factor linked to Rettʹs syndrome

938

Neurotrophic factors and regulation of mood: Role of exercise, diet and metabolism

939

Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy

940

Neurotrophic factors in the therapy of diabetic neuropathy

941

Neurotrophic peptide aldehydes: Solid phase synthesis of fellutamide B and a simplified analog

942

Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation

943

Neurotrophin receptor and tyrosine hydroxylase gene expression in aged sympathetic neurons

944

Neurotrophin regulation of development of vagal innervation of the gastrointestinal tract

945

Neurotrophin secretory pathways and synaptic plasticity Review Article

946

NEUROTROPHIN-3 (NT-3) PROMOTES REPARATIVE NEOVASCULARIZATION AND BLOOD FLOW RECOVERY IN A MOUSE MODEL OF LIMB ISCHEMIA

947

Neurotrophin-3 modifies potassium currents in isolated inner hair cells from guinea-pig cochlea

948

Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons

949

Neurotrophins and Netrins Require Calcineurin/NFAT Signaling to Stimulate Outgrowth of Embryonic Axons

950

Neurotrophins and their receptors in early development of the mammalian nervous system

951

Neurotrophins and their receptors in the pigeon caecal tonsil: An immunohistochemical study

952

Neurotrophins and their receptors in the pigeon caecal tonsil: An immunohistochemical study

953

Neurotropin alleviates rat osteocarcinoma pain via P2X3 receptor activation in the midbrain periaqueductal gray

954

Neurotropism and neuropathological effects of selected rhabdoviruses on intranasally-infected newborn mice

955

Neurotuberculosis among Filipino children: an 11 years experience at the Philippine Childrenʹs Medical Center

956

Neurovascular bundle resection: Does it improve the margins?

957

Neuro-vascular central nervous recording/stimulating system: Using nanotechnology probes

958

Neurovascular compression syndrome with Meniereʹs disease—a report of the treatment of a patient with microvascular decompression

959

NEURO-VASCULAR CONFLICT AS CAUSATIVE FACTOR IN IDIOPATHIC TRIGEMINAL NEURALGIA

960

Neurovascular contact and blood pressure response in young, healthy, normotensive men

961

Neurovascular injury during removal of levonorgestrel implants

962

Neurovascular intervention

963

Neurovascular interventions

964

Neurovascular intervention-studies and strategies

965

Neurovegetative dystonia—Psychiatric evaluation of 40 patients diagnosed by general physicians in Brazil

966

Neurovegetative symptoms and complaints before and after voice therapy for nonorganic habitual dysphonia

967

Neurovegetative Symptoms in Multiple Sclerosis: Relationship to Depressed Mood, Fatigue, and Physical Disability

968

Neuroviual rehabilitation: recent development and future direction

969

Neurulation in the cranial region - normal and abnormal

970

Neustonic microplastic and zooplankton in the North Western Mediterranean Sea

971

NEUTIT: a computer program for evaluating equivalence volumes and ionization constants in polar non-aqueous or partially aqueous media

972

Neutra and Kreutzer Reply to "Invited Commentary: Sensitivities to Chemicals Context and Implications" by Kipen and Fiedler

973

Neutra and Kreutzer Reply to "Invited Commentary: Sensitivities to Chemicals Context and Implications" by Kipen and Fiedler

974

Neutral (beta)-diketiminato nickel(II) monoalkyl complexes

975

Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase

976

Neutral 5-substituted 4-indazolylaminoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase

977

Neutral acetohydroxamic acid coordination to a mononuclear Ni(II) center stabilized by an intramolecular hydrogen-bonding interaction

978

Neutral additives enhance the metal-chelate affinity adsorption of nucleic acids: Role of water activity

979

Neutral adsorptive capture of particles by membranes: network modeling near the membrane isoelectric point

980

Neutral aldoses as source indicators for marine snow

981

Neutral aluminum and gallium four particle complexes in silicon carbide polytypes

982

Neutral aluminum and gallium four particle complexes in silicon carbide polytypes

983

Neutral amino acids monitoring in phenylketonuric plasma microdialysates using micellar electrokinetic chromatography and laser-induced fluorescence detection

984

Neutral analyte focusing by micelle collapse in micellar electrokinetic chromatography

985

Neutral and anionic CuO2: an ab inito study

986

Neutral and cationic (η6-arene)-ruthenium(II) complexes containing the iminophosphorane–phosphine ligand Ph2PCH2P(N-p-C5F4N)Ph2: influence of the arene ring in catalytic transfer hydrogenation of cyclohexanone

987

Neutral and cationic cyclometallated Ir(III) complexes of anthra[1,2-d]imidazole-6,11-dione-derived ligands: Syntheses, structures and spectroscopic characterisation

988

Neutral and cationic Fe(II) β-diketiminate complexes

989

Neutral and cationic multinuclear half-sandwich rhodium and iridium complexes coordinated to poly(propyleneimine) dendritic scaffolds: Synthesis and cytotoxicity

990

Neutral and cationic osmium(II)-arene metallodendrimers: Synthesis, characterisation and anticancer activity

991

Neutral and cationic palladium(II) and platinum(II) complexes of 2,2′-dipyridylamine with saccharinate: Syntheses, spectroscopic, structural, fluorescent and thermal studies

992

Neutral and cationic rare-earth metal alkyl complexes that contain bis(2-methoxyethyl)(trimethylsilyl)amine, a neutral [ONO]-type ligand

993

Neutral and cationic trimethylsilylmethyl complexes of the rare earth metals supported by a crown ether: synthesis and structural characterization

994

Neutral and charged current cross sections at high Q2 at HERA Original Research Article

995

Neutral and charged donor in a 3D quantum dot

996

Neutral and charged excitons in a quantum tube

997

Neutral and charged magnetic excitons in finite-width quantum rings

998

Neutral and charged polymers at interfaces

999

Neutral and charged polymers at interfaces

1000

Neutral and dianionic iron and ruthenium 1,4-diphosphabutadiene complexes

بازگشت